Cargando…

Efficacy and safety of second‐line chemotherapy for patients with advanced non‐small cell lung cancer complicated by interstitial lung disease

BACKGROUND: Treatment of non‐small cell lung cancer (NSCLC) patients with interstitial lung disease (ILD) is limited because of the risk of its acute exacerbation (AE). Furthermore, the efficacy and safety of second‐line chemotherapy for these patients is unclear. METHODS: To investigate the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Otsuka, Kenji, Nokihara, Hiroshi, Mitsuhashi, Atsushi, Ozaki, Ryohiko, Yabuki, Yohei, Yoneda, Hiroto, Ogino, Hirokazu, Nishioka, Yasuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626311/ https://www.ncbi.nlm.nih.gov/pubmed/36106507 http://dx.doi.org/10.1111/1759-7714.14645

Ejemplares similares

Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma
por: Yoneda, Hiroto, et al.
Publicado: (2021)

Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion
por: Nokihara, Hiroshi, et al.
Publicado: (2022)

A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumab
por: Sako, Masahiro, et al.
Publicado: (2021)

FoundationOne CDx detected an uncovered variant of epidermal growth factor receptor exon 19 deletion by Oncomine Dx target test in a patient with lung adenocarcinoma
por: Takahashi, Hiroki, et al.
Publicado: (2023)

Radiation therapy induces an abscopal effect and upregulates programmed death‐ligand 1 expression in a patient with non‐small cell lung cancer
por: Morita, Yutaka, et al.
Publicado: (2022)

Immune checkpoint inhibitor-related pneumonitis with atypical radiologic features in a patient with anti-aminoacyl-tRNA synthetase antibody
por: Ichihara, Seiya, et al.
Publicado: (2022)

A multicenter, open‐label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non‐small cell lung cancer
por: Yabuki, Yohei, et al.
Publicado: (2023)

Programmed death (PD)‐1/PD‐ligand 1 blockade mediates antiangiogenic effects by tumor‐derived CXCL10/11 as a potential predictive biomarker
por: Mitsuhashi, Atsushi, et al.
Publicado: (2021)

S‐1 eliminates MDSCs and enhances the efficacy of PD‐1 blockade via regulation of tumor‐derived Bv8 and S100A8 in thoracic tumor
por: Nguyen, Na T., et al.
Publicado: (2022)

Analysis of the chemotactic factors for tumor-infiltrating fibrocytes and their prognostic significances in lung cancer
por: Tobiume, Makoto, et al.
Publicado: (2022)

Multidisciplinary treatment of skeletal muscle metastasis from lung cancer: A case of triceps muscle metastasis of lung squamous cell cancer
por: Haji, Keiko, et al.
Publicado: (2021)

Development, validation, and comparison of gene analysis methods for detecting EGFR mutation from non-small cell lung cancer patients-derived circulating free DNA
por: Hanibuchi, Masaki, et al.
Publicado: (2019)

Early mortality factors in immune checkpoint inhibitor monotherapy for advanced or metastatic non-small cell lung cancer
por: Takeuchi, Eiji, et al.
Publicado: (2022)

Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors
por: Takeuchi, Eiji, et al.
Publicado: (2023)

A New Quinoline Derivative MS‐209 Reverses Multidrug Resistance and Inhibits Multiorgan Metastases by P‐glycoprotein‐expressing Human Small Cell Lung Cancer Cells
por: Nokihara, Hiroshi, et al.
Publicado: (2001)

Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan
por: Minegishi, Yuji, et al.
Publicado: (2020)

Interstitial lung disease associated with adjuvant and neoadjuvant chemotherapy in early breast cancer
por: Tezuka, Kenji, et al.
Publicado: (2021)

Lenvatinib-induced Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma
por: Imakura, Takeshi, et al.
Publicado: (2021)

Biomarkers for interstitial lung disease and acute-onset diffuse interstitial lung disease in rheumatoid arthritis
por: Furukawa, Hiroshi, et al.
Publicado: (2021)

Pulmonary hypertension due to unclassified interstitial lung disease in a Pembroke Welsh corgi
por: MORITA, Tomoya, et al.
Publicado: (2018)

Radiation-associated Angiosarcoma Presenting as Massive Pleural Effusion
por: Ogino, Hirokazu, et al.
Publicado: (2021)

Impact of accurate diagnosis of interstitial lung diseases on postoperative outcomes in lung cancer
por: Azuma, Yoko, et al.
Publicado: (2022)

Interstitial lung abnormality (ILA) and nonspecific interstitial pneumonia (NSIP)
por: Hino, Takuya, et al.
Publicado: (2021)

Risk factors of immune checkpoint inhibitor-related interstitial lung disease in patients with lung cancer: a single-institution retrospective study
por: Okada, Naoto, et al.
Publicado: (2020)

Interstitial lung disease induced by docetaxel and ramucirumab chemotherapy after nivolumab treatment
por: Okeya, Komugi, et al.
Publicado: (2020)

Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
por: Zhou, Qian, et al.
Publicado: (2023)

Surgical lung biopsy for interstitial lung diseases—a single center study of 129 patients
por: Otsuka, Hajime, et al.
Publicado: (2022)

Prevention of Pemetrexed-Induced Rash Using Low-Dose Corticosteroids: A Phase II Study
por: Sakurada, Takumi, et al.
Publicado: (2022)

Sexual Dimorphism in Interstitial Lung Disease
por: Ozaki, Mari, et al.
Publicado: (2022)

Sensitivity of transbronchial lung cryobiopsy in the diagnosis of different interstitial lung diseases
por: Zaizen, Yoshiaki, et al.
Publicado: (2022)

Necessity of Multi-Step Surgical Treatment for Patients with Interstitial Lung Disease and a Pneumothorax
por: Iyoda, Akira, et al.
Publicado: (2022)

Possibility of Interstitial Lung Disease as a Phlebosclerotic Colitis Manifestation
por: Takemura, Tomoyasu, et al.
Publicado: (2018)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
por: Sugiyama, Yumiko, et al.
Publicado: (2018)

Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study
por: Koda, Keigo, et al.
Publicado: (2022)

Interstitial lung abnormalities and physical function
por: Axelsson, Gisli Thor, et al.
Publicado: (2018)

An Autopsy Case of Aortic Intimal Sarcoma Initially Diagnosed as Polyarteritis Nodosa
por: Toyoda, Yuko, et al.
Publicado: (2016)

Pulmonary capillary hemangiomatosis-predominant vasculopathy in a patient with rheumatoid arthritis-associated interstitial lung disease: An autopsy report
por: Nakamura, Junichi, et al.
Publicado: (2020)

Fatal interstitial lung disease caused by Panitumumab-containing chemotherapy regimen
por: Al-asadi, Osamah, et al.
Publicado: (2018)

Current Developments in Interstitial Lung Disease
por: Mori, Shunsuke, et al.
Publicado: (2016)

Outcome and prognosis of secondary lung cancer surgery with interstitial lung disease
por: Ichinokawa, Hideomi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ntc5bomv5njq2n3bndmekqk7t7